This case on behalf of non-medical faculty follows Lieff Cabraser Heimann & Bernstein LLP’s successful similar action against Duke on behalf of medical faculty that led to a $54.5 million settlement in 2019. May 27, 2020, Durham, North Carolina—(BUSINESSWIRE)—Lieff Cabraser, Edelstein & Payne, and Elliot Morgan Parsonage announce the filing of a class action labor
As reported by Law360 (subscription), a New York federal judge has granted class certification in an antitrust lawsuit wherein Lieff Cabraser and co-counsel represent a group of pharmaceutical purchasers, union benefit plans, and other buyers of Allergan’s blockbuster dry-eye disease drug Restasis. The sweeping litigation accuses the drugmaker of misconduct intended
The American Bar Association Section of Antitrust Law recently submitted comments to the Federal Trade Commission in connection with the January 2020 FTC workshop on “Non-Competes in the Workplace: Examining Antitrust and Consumer Protection Issues.” In section two of the submission, Lieff Cabraser partner Dean M. Harvey provided detailed commentary on the “Impact of Non-compete
First-of-its-kind class action antitrust case brought by Lieff Cabraser and Justice Catalyst Law, Public Counsel, the National Consumer Law Center, and Towards Justice alleging that insurance companies in California conspired to unlawfully inflate California bail bond premiums will move forward to discovery and trial On April 13, 2020, Judge Jon S. Tigar of the U.S.
Lieff Cabraser partner Dean M. Harvey recently participated in panel discussion on “No-Poach: Assessing Risk in Uncertain Seas” as a part of the American Bar Association’s 68th Annual Antirust Law Section Virtual Spring Meeting. The panel was presented by the Cartel & Criminal Practice and Trial Practice Committees and will be turned into a podcast along with
As reported by Law360 (Subscription), U.S District Judge Joy Flowers Conti has indicated she is close to granting preliminary approval to a $48.95 million settlement of the antitrust lawsuit in which employee plaintiffs alleged Knorr-Bermse AG and Wabtec Corp. improperly agreed not to hire each other’s employees resulting in suppressed and lost wages. The settlement
As reported by Law360 (subscription), a Pennsylvania federal judge has ordered that a group of chemical manufacturers face class action litigation accusing them of conspiring to manipulate the prices of two chemicals used to make polyurethane. The complaint alleges that BASF, Covestro LLC and Dow Chemical Co. used plant closures and limited supplies to illegally
Proposed settlements with world’s dominant railway equipment suppliers will provide $48.95 million for employees who alleged their compensation was adversely impacted by an agreement between Knorr and Wabtec not to poach each other’s employees Lieff Cabraser Heimann & Bernstein, LLP and Fine, Kaplan and Black, R.P.C. announce a total of $48.95 million in settlements to
Kellum is Fourth Executive to Be Charged in Ongoing Investigation A former senior executive pleaded guilty today for his role in a conspiracy to fix prices, rig bids, and allocate customers for generic drugs, the Department of Justice has announced. According to court documents, from at least March 2013 until at least June 2015, Hector Armando
If You Bought or Provided Reimbursement for the Anticoagulant Medications Lovenox® or Generic Enoxaparin Between September 21, 2011 and September 30, 2015 You Could Get Money from Class Action Settlements Totaling $120 Million Proposed Settlements totaling $120 million have been reached in a class action lawsuit regarding the price that uninsured consumers, hospitals, and third-party